Liquid Biopsy Market Size

1. GLOBAL LIQUID BIOPSY MARKET: FOCUS ON PRODUCTS AND SERVICES, THERAPEUTIC APPLICATIONS, CLINICAL APPLICATIONS, CIRCULATING BIOMARKERS, COUNTRY ANALYSIS (16 COUNTRIES), INDUSTRY INSIGHTS, AND COMPETITIVE LANDSCAPE - ANALYSIS AND FORECAST, 2018-2028 Key Questions Answered in the Report: • What are the key features of the liquid biopsy technology promoting its incorporation in different clinical applications? What are the key advantages of the liquid biopsy technology over tissue biopsy? How did the liquid biopsy market evolve and what is its scope in the future? What are the major market drivers, challenges, and opportunities in the global liquid biopsy market? What are the key developmental strategies which are implemented by the key players to stand out in this market? What are the leading companies dominating the global liquid biopsy market? Which therapeutic application market would witness massive incorporation of the liquid biopsy technology in the forecast period? Products based on which circulating biomarker are anticipated to witness massive rise in their demand in the forecast period? How would the scope of clinical application of the liquid biopsy technology evolve in the forecast period? What are investors’ perceptions about the global liquid biopsy market? Who are the leading stakeholders of the market holding significant share in the market’s intellectual property? What are the key companies which made substantial investments to aid technological advancements in the market? What are the regulations pertaining to the global liquid biopsy market? What are the initiatives implemented by different government bodies to combat the growing prevalence of different types of cancer? What was the market value of the leading segments and sub-segments of the global liquid biopsy market? How will each segment of the global liquid biopsy market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028? How will the industry evolve during the forecast period 2018-2028? Which geographical location will contribute to the highest sales of the global liquid biopsy market during the forecast period? MORE THAN 70 COMPANIES RESEARCHED ACROSS THE VALUE CHAIN • • • • • • METICULOUS COMPILATION OF MORE THAN 700 RESEARCH HOURS • • • • EXCLUSIVE INSIGHTS FROM IN-DEPTH EXPERT INTERVIEWS • • • CONTAINS 35 MARKET DATA TABLES AND 244 FIGURES SPREAD ACROSS 315 PAGES • • • • 1 www.bisresearch.com  sales@bisresearch.com

2. TABLE OF CONTENTS • Historical Trends • Comparative Analysis of Tissue Biopsy and Liquid Biopsy • Clinical Applications of Liquid Biopsy • Trends for Liquid Biopsy • Assumptions and Limitations for Market Size Calculations • Global Liquid Biopsy Market Scenario COMPANY PROFILES • Adaptive Biotechnologies • ANGLE plc • Biocept, Inc. • Bio-Rad Laboratories, Inc. • Cynvenio Biosystems, Inc. • Chronix Biomedical • Epic Sciences, Inc. • F. Hoffmann-La Roche AG • GUARDANT HEALTH, INC • Illumina, Inc. • MDxHealth, Inc. • Menarini Silicon Biosystems, Inc. • Myriad Genetics, Inc. • Natera, Inc. • NeoGenomics Laboratories, Inc. • Personal Genome Diagnostics, Inc. • Qiagen N.V. • Resolution Bioscience, Inc. • Sysmex Corporation • Impact Analysis • Market Drivers • Market Restraints • Market Opportunities MARKET OVERVIEW • Key Strategies and Developments • Market Share Analysis • Growth Share Analysis • Global Comprehensive Competitive Index (CCI) • Industry Attractiveness MARKET DYNAMICS • Introduction • Patent Analysis • Funding Scenario • Regulatory Bodies • Clinical Laboratory Improvement Amendments (CLIA) Program • Government Initiatives COMPETITIVE INSIGHTS INDUSTRY INSIGHTS RESEARCH SCOPE & METHODOLOGY • Circulating Tumor DNA (cTDNA) • Circulating Tumor Cells (CTCs) • Cell-Free DNA (cfDNA) • Extracellular Vesicles and Others GLOBAL LIQUID BIOPSY MARKET (BY CIRCULATING BIOMARKERS) • Report Scope • Global Liquid Biopsy Market: Research Methodology • Tests/Services • Kits and Consumables • Instruments GLOBAL LIQUID BIOPSY MARKET (BY PRODUCTS) • Lung Cancer • Breast Cancer • Prostate Cancer • Colorectal Cancer • Melanoma Cancer • Other Types of Cancer • Non-Oncology Application GLOBAL LIQUID BIOPSY MARKET (BY THERAPEUTIC APPLICATION) GLOBAL LIQUID BIOPSY MARKET (BY CLINICAL APPLICATIONS) • Treatment Monitoring • Prognosis and Reoccurrence Monitoring • Treatment Selection • Diagnosis and Screening GLOBAL LIQUID BIOPSY MARKET (BY REGION) • Analysis of Growth Potential of Different Countries: Global Liquid Biopsy Market • North America • Europe • Asia-Pacific • Latin America and Middle East • Rest-of-the-World VIEW COMPLETE TABLE OF CONTENTS 2 www.bisresearch.com  sales@bisresearch.com

3. LIST OF TABLES 20 The U.S: Prevalence of Different Types of Cancer, 2015-2030 1 Cancer Incidences (by Region), 2015 2 Tissue Biopsy vs. Liquid Biopsy 21 Canada: Prevalence of Different Types of Cancer, 2015-2030 3 Impact Analysis 4 Governmental Initiatives for the Market Growth of Precision Medicine 22 Germany: Prevalence of Different Types of Cancer, 2015-2030 5 Incidence of Leading Cancer Types (by Region), 2015 23 France: Prevalence of Different Types of Cancer, 2015-2030 6 List of Regulatory Bodies across the World 24 The U.K.: Prevalence of Different Types of Cancer, 2015-2030 7 List of Regulatory Authorities involved in CLIA Program 25 Italy: Prevalence of Different Types of Cancer, 2015-2030 8 Government Initiatives 9 Lung Cancer Incidence in Top Countries, 2012- 2030 26 Spain: Prevalence of Different Types of Cancer, 2015-2030 10 Breast Cancer Incidence in Top Countries, 2012- 2030 27 China: Prevalence of Different Types of Cancer, 2015-2030 11 Prostate Cancer Incidence in Top Countries, 2012-2030 28 Japan: Prevalence of Different Types of Cancer, 2015-2030 12 Colorectal Cancer Incidence in Top Countries, 2012-2030 29 India: Prevalence of Different Types of Cancer, 2015-2030 13 Estimated Incidence and Mortality of Melanoma Worldwide in 2012 30 Australia: Prevalence of Different Types of Cancer, 2015-2030 14 Melanoma Cancer Incidence in Top Countries, 2012-2030 31 South Korea: Prevalence of Different Types of Cancer, 2015-2030 15 Ovarian Cancer Incidence in Top Countries, 2012-2030 32 Singapore: Prevalence of Different Types of Cancer, 2015-2030 16 Stomach Cancer Incidence in Top Countries, 2012-2030 33 Brazil: Prevalence of Different Types of Cancer, 2015-2030 17 Analysis of Growth Potential (by Countries) 34 Mexico: Prevalence of Different Types of Cancer, 2015-2030 18 Prevalence of Different Types of Cancer (by Country), 2017 35 Saudi Arabia: Prevalence of Different Types of Cancer, 2015-2030 19 Prevalence of Different Types of Cancer (by Country), 2017 3 www.bisresearch.com  sales@bisresearch.com

4. LIST OF FIGURES 1 2 3 4 5 6 Few Citations of Liquid Biopsy Facts about Cancer Market Drivers and Market Restraints Market Statistics Global Liquid Biopsy Market, 2017-2028 Global Liquid Biopsy Market (by Products), 2017 and 2028 Global Liquid Biopsy Market (by Circulating Biomarker), 2017-2028 Global Liquid Biopsy Market (by Clinical Application), 2017-2028 Global Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Global Liquid Biopsy Market (by Region), 2017- 2028 Adoption Rate: Tissue Biopsy vs. Liquid biopsy Different Types of Biomarkers in Liquid Biopsy Evolution of Liquid Biopsy with Progress in Molecular Technologies and Biomarker Discovery Workflow Model of Tissue and Liquid Biopsy Clinical Applications of Liquid Biopsy Global Liquid Biopsy Market, 2017-2028 Market Dynamics of Global Liquid Biopsy Market Competitive Landscape, January 2015-July 2018 Share of Key Developments and Strategies, January 2015-July 2018 Mergers and Acquisitions Share (by Companies), January 2015-July 2018 Business Expansions Share (by Companies), January 2015-July 2018 Awards, Recognitions, Certifications and Others Share (by Companies), January 2015-July 2018 Product Launches Share (by Companies), January 2015-July 2018 Joint Ventures, Partnerships, and Collaborations Share (by Companies), January 2015-July 2018 Market Share Analysis: Global Liquid Biopsy Market, 2016 and 2017 Growth Share Matrix for Global Liquid Biopsy Market (by Prominent Companies), 2018-2020 Growth Share Matrix for Global Liquid Biopsy Market (by Therapeutic Application), 2017 Growth Share Matrix for Global Liquid Biopsy Market (by Biomarker Type), 2017 Growth Share Matrix for Global Liquid Biopsy Market (by Clinical Application), 2017 Global Comprehensive Competitive Index (by Market Leaders), 2017 31 32 Porter’s Five Forces Analysis Bargaining Power of Suppliers: Overall Impact, 2014-2028 Bargaining Power of Buyers: Overall Impact, 2014-2028 Threat of New Entrant: Overall Impact, 2014- 2028 Threat of Substitute Products: Overall Impact, 2014-2028 Intensity of Competitive Rivalry: Overall Impact, 2014-2028 Industry Insights, January 2015-May 2018 Patent Share (by Assignee), January 2015-July 2018 Research Investments by Companies, $Million, January 2015-Decemeber 2017 Categorization of Test Methods (by FDA) Different Circulating Biomarkers Global Liquid Biopsy Market (by Circulating Biomarker), 2017 and 2028 Global Liquid Biopsy Market (by cTDNA), 2017- 2028 CTCs vs. cTDNA Analysis Global Liquid Biopsy Market (by CTCs), 2017- 2028 Global Liquid Biopsy Market (by cfDNA), 2017- 2028 Global Liquid Biopsy Market (by Extracellular Vesicles and Others), 2017-2028 Global Liquid Biopsy Market (by Products) Global Liquid Biopsy Market (by Products), 2017- 2028 Global Liquid Biopsy Market (by Tests/Services), 2017-2028 Global Liquid Biopsy Market (by Kits and Consumables), 2017-2028 Global Liquid Biopsy Market (by Instruments), 2017-2028 Global Liquid Biopsy Market (by Therapeutic Application) Global Liquid Biopsy Market (by Therapeutic Applications), 2017-2028 Types of Lung Cancer Global Liquid Biopsy Market (by Lung Cancer), 2017-2028 Types of Breast Cancer Global Liquid Biopsy Market (by Breast Cancer), 2017-2028 Global Liquid Biopsy Market (by Prostate Cancer), 33 34 35 7 36 8 37 38 9 10 39 11 12 13 40 41 42 14 15 16 17 18 19 43 44 45 46 47 20 48 49 21 22 50 23 51 24 52 25 53 26 54 27 55 56 28 29 57 58 30 59 4 www.bisresearch.com  sales@bisresearch.com

5. LIST OF FIGURES 2017-2028 Global Liquid Biopsy Market (by Colorectal Cancer), 2017-2028 Global Liquid Biopsy Market (by Melanoma Cancer), 2017-2028 Global Liquid Biopsy Market (by Other Types of Cancer), 2017-2028 Global Liquid Biopsy Market (by Non-Oncology Applications), 2017-2028 Global Liquid Biopsy Market (by Clinical Applications) Global Liquid Biopsy Market (by Clinical Applications), 2017-2028 Global Liquid Biopsy Market (by Treatment Monitoring), 2017-2028 Global Liquid Biopsy Market (by Prognosis and Reoccurrence Monitoring), 2017-2028 Global Liquid Biopsy Market (by Treatment Selection), 2017-2028 Global Liquid Biopsy Market (by Diagnosis and Screening), 2017-2028 Global Liquid Biopsy Market Scenario, 2017 and 2028 Global Liquid Biopsy Market (by Region), 2017- 2028 Global Liquid Biopsy Market Share (by Region), 2017 and 2028 Cluster Analysis: Global Liquid Biopsy Market Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028 Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028 Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028 Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028 North America: Liquid Biopsy Market, (2017- 2028) North America: Market Dynamics North America: Liquid biopsy Market (by Country), 2017-2028 The U.S: Liquid Biopsy Market, 2017-2028 The U.S: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Canada: Liquid Biopsy Market, 2017-2028 Canada: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Europe: Liquid Biopsy Market, 2017-2028 Europe: Market Dynamics 87 Europe: Liquid Biopsy Market (by Country), 2017- 2028 Germany: Liquid Biopsy Market, 2017-2028 Germany: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 France: Liquid Biopsy Market, 2017-2028 France: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 The U.K.: Liquid Biopsy Market, 2017-2028 The U.K.: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Italy: Liquid Biopsy Market, 2017-2028 Italy: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Spain: Liquid Biopsy Market, 2017-2028 Spain: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 Rest-of-Europe: Liquid Biopsy Market, 2017-2028 Asia-Pacific: Liquid Biopsy Market, 2017-2028 100 Asia-Pacific: Market Dynamics 101 Asia Pacific: Liquid Biopsy Market (by Country), 2017-2028 102 China: Liquid Biopsy Market, 2017-2028 103 China: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 104 Japan: Liquid Biopsy Market, 2017-2028 105 Japan: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 106 India: Liquid Biopsy Market, 2017-2028 107 India: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 108 Australia: Liquid Biopsy Market, 2017-2028 109 Australia: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 110 South Korea: Liquid Biopsy Market, 2017-2028 111 South Korea: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 112 Singapore: Liquid Biopsy Market, 2017-2028 113 Singapore: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 114 Rest-of-Asia Pacific: Liquid Biopsy Market, 2017- 2028 115 Latin America: Liquid Biopsy Market, 2017-2028 116 Latin America: Market Dynamics 117 Latin America: Liquid Biopsy Market (by Country), 2017-2028 118 Brazil: Liquid Biopsy Market, 2017-2028 60 88 89 61 62 90 91 63 92 93 64 65 94 95 66 96 97 67 68 98 99 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 5 www.bisresearch.com  sales@bisresearch.com

6. LIST OF FIGURES 119 Brazil: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 120 Mexico: Liquid Biopsy Market, 2017-2028 121 Mexico: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 122 Saudi Arabia: Liquid Biopsy Market, 2017-2028 123 Saudi Arabia: Liquid Biopsy Market (by Therapeutic Application), 2017-2028 124 Rest-of-Latin America and Middle East: Liquid Biopsy Market, 2017-2028 125 Rest-of-the-World: Liquid Biopsy Market, 2017- 2028 126 Shares of Key Company Profiles 127 Abcodia Ltd.: Product Offerings for Global Liquid Biopsy Market 128 Abcodia Ltd.: SWOT Analysis 129 Adaptive Biotechnologies: Product Offerings for Global Liquid Biopsy Market 130 Adaptive Biotechnologies: SWOT Analysis 131 ANGLE plc: Product Offerings for Global Liquid Biopsy Market 132 ANGLE plc: Overall Financials, 2015-2017 133 ANGLE plc: Revenue (by Region), 2016 and 2017 134 ANGLE plc: R&D Expense, 2015-2017 135 ANGLE plc: Revenue Forecast, 2015-2020 136 ANGLE plc: Global Presence 137 ANGLE plc: SWOT Analysis 138 Biocept, Inc.: Product Offerings for Global Liquid Biopsy Market 139 Biocept, Inc.: Overall Financials, 2015-2017 140 Biocept, Inc.: R&D Expense, 2015-2017 141 Biocept, Inc.: Revenue Forecast, 2015-2020 142 Biocept, Inc.: SWOT Analysis 143 Bio-Rad Laboratories, Inc.: Product Offerings for Global Liquid Biopsy Market 144 Bio-Rad laboratories, Inc.: Overall Financials, 2015-2017 145 Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2015-2017 146 Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017 147 Bio-Rad Laboratories, Inc.: R&D Expense, 2015- 2017 148 Bio-Rad Laboratories, Inc.: Revenue Forecast, 2015-2020 149 Bio-Rad Laboratories, Inc.: Global Presence 150 Bio-Rad Laboratories, Inc.: SWOT Analysis 151 Cynvenio Biosystems, Inc.: Overall Product Portfolio 152 Cynvenio Biosystems, Inc.: SWOT Analysis 153 Chronix Biomedical: Product Offerings for Global Liquid Biopsy Market 154 Chronix Biomedical: SWOT Analysis 155 Epic Sciences, Inc.: Product Offerings for Global Liquid Biopsy Market 156 Epic Sciences, Inc.: SWOT Analysis 157 F. Hoffmann-La Roche AG: Product Offerings for Global Liquid Biopsy Market 158 F. Hoffmann-La Roche AG: Overall Financials, 2015-2017 159 F. Hoffmann-La Roche AG: Revenue (by Business Segment), 2015-2017 160 F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics Sub-division), 2015-2017 161 F. Hoffmann-La Roche AG: Revenue (by Region), 2015-2017 162 F. Hoffmann-La Roche AG: R&D Expense, 2015- 2017 163 F. Hoffmann-La Roche AG: Revenue Forecast, 2015-2020 164 F. Hoffmann-La Roche AG: Global Presence 165 F. Hoffmann-La Roche AG: SWOT Analysis 166 GUARDANT HEALTH, INC.: Product Offerings for Global Liquid Biopsy Market 167 GUARDANT HEALTH, INC.: SWOT Analysis 168 Illumina, Inc.: Product Offerings for Global Liquid Biopsy Market 169 Illumina, Inc.: Overall Financials, 2015-2017 170 Illumina, Inc.: Revenue (by Business Segment), 2015-2017 171 Illumina, Inc.: Revenue (by Region), 2015-2017 172 Illumina, Inc.: R&D Expense, 2015-2017 173 Illumina, Inc.: Revenue Forecast, 2015-2020 174 Illumina, Inc.: Global Presence 175 Illumina, Inc.: SWOT Analysis 176 MDxHealth, Inc.: Product Offerings for Global Liquid Biopsy Market 177 MDxHealth, Inc.: Overall Financials, 2015-2017 178 MDxHealth, Inc.: R&D Expanse, 2015-2017 179 MDxHealth, Inc.: Revenue Forecast, 2015-2017 180 MDxHealth, Inc.: Global Presence 181 MDxHealth, Inc.: SWOT Analysis 182 Menarini Silicon Biosystems, Inc.: Product Offerings for Global Liquid Biopsy Market 6 www.bisresearch.com  sales@bisresearch.com

7. LIST OF FIGURES 183 Menarini Silicon Biosystems, Inc.: SWOT Analysis 184 Myriad Genetics, Inc.: Product Offerings for Global Liquid Biopsy Market 185 Myriad Genetics, Inc.: Overall Financials, 2015- 2017 186 Myriad Genetics, Inc.: Revenue (by Business Segment), 2015-2017 187 Myriad Genetics, Inc.: Revenue (by Region), 2015-2017 188 Myriad Genetics, Inc.: R&D Expense, 2015-2017 189 Myriad Genetics, Inc.: Revenue Forecast, 2015- 2020 190 Myriad Genetics, Inc.: Global Presence 191 Myriad Genetics, Inc.: SWOT Analysis 192 Natera, Inc.: Product Offerings for Global Liquid Biopsy Market 193 Natera, Inc.: Overall Financials, 2015-2017 194 Natera, Inc.: Revenue (by Region), 2015-2017 195 Natera, Inc.: R&D Expense, 2015-2017 196 Natera, Inc.: Revenue Forecast, 2015-2020 197 Natera, Inc.: Global Presence 198 Natera, Inc.: SWOT Analysis 199 NeoGenomics Laboratories, Inc.: Product Offerings for Global Liquid Biopsy Market 200 NeoGenomics Laboratories, Inc.: Overall Financials, 2015-2017 201 NeoGenomics Laboratories, Inc.: Revenue (by Business Segment), 2015-2017 202 NeoGenomics Laboratories, Inc.: R&D Expense, 2015-2017 203 NeoGenomics Laboratories, Inc.: Revenue Forecast, 2015-2020 204 NeoGenomics Laboratories, Inc.: Global Presence 205 NeoGenomics Laboratories, Inc.: SWOT Analysis 206 Personal Genome Diagnostics, Inc.: Product Offerings for Global Liquid Biopsy Market 207 Personal Genome Diagnostics, Inc.: SWOT Analysis 208 Qiagen N.V.: Product Offerings for Global Liquid Biopsy Market 209 Qiagen N.V.: Overall Financials, 2015-2017 210 Qiagen N.V.: Revenue (by Business Segment), 2015-2017 211 Qiagen N.V.: Revenue (by Region), 2015-2017 212 Qiagen N.V.: R&D Expense, 2015-2017 213 Qiagen N.V.: Revenue Forecast, 2015-2020 214 Qiagen N.V.: Global Presence 215 Qiagen N.V.: SWOT Analysis 216 Resolution Bioscience, Inc.: Product Offerings for Global Liquid Biopsy Market 217 Resolution Bioscience, Inc.: SWOT Analysis 218 Sysmex Corporation: Product Offerings for Global Liquid Biopsy Market 219 Sysmex Corporation: Overall Financials, 2015- 2017 220 Sysmex Corporation: Revenue (by Business Segment), 2016 and 2017 221 Sysmex Corporation: Revenue (by Business Segment), 2015 222 Sysmex Corporation: Revenue by Product Type (2015-2017) 223 Sysmex Corporation: Revenue (by Region), 2015- 2017 224 Sysmex Corporation: R&D Expense, 2015-2017 225 Sysmex Corporation: Revenue Forecast, 2015- 2020 226 Sysmex Corporation: Global Presence 227 Sysmex Corporation: SWOT Analysis 228 Thermo Fisher Scientific Inc.: Product Offerings for Global Liquid Biopsy Market 229 Thermo Fisher Scientific Inc.: Overall Financials, 2015-2017 230 Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2015-2017 231 Thermo Fisher Scientific Inc.: Revenue (by Region), 2015-2017 232 Thermo Fisher Scientific Inc.: R&D Expense, 2015-2017 233 Thermo Fisher Scientific Inc.: Revenue Forecast, 2015-2020 234 Thermo Fisher Scientific Inc.: Global Presence 235 Thermo Fisher Scientific Inc.: SWOT Analysis 236 Global Liquid Biopsy: Market Segmentation 237 Global Liquid Biopsy Market Segmentation 238 Primary Research 239 Secondary Research 240 Data Triangulation 241 Top-down Approach (Segment-wise Analysis) 242 Bottom-up Approach (Segment-wise Analysis) 243 Assumptions and Limitations 244 Considered Factors for Data Prediction and Modelling 7 www.bisresearch.com  sales@bisresearch.com

8. 1 Research Scope & BIS Methodology 1.1 Scope of the Report The report constitutes of an in-depth study of the liquid biopsy market, including a thorough analysis of the products and services across different regions. The study also presents a detailed analysis of the market trends and the market size for the period 2017 to 2028 wherein 2017 is the base year and the years from 2018 to 2028 constitute of the forecast period. The report covers all the prevalent trends which are expected to play a major role in the growth of the market over the forecast period. It also highlights various drivers, restraints, and opportunities which are expected to influence the market’s growth during the forecast period. The scope of this report is focused on the global liquid biopsy market, products, their market dynamics, growth prospect mapping, SWOT analysis, Porter’s Five Forces and country-wise analysis. The study provides a holistic perspective on the market growth in terms of revenue estimates across different geographies which include North America, Europe, Asia-Pacific (APAC), Latin America and Middle East, and Rest-of-the-World (RoW). The report provides cross-sectional analysis of the global liquid biopsy market in terms of market estimates and projections for different therapeutic application across different countries. The regions have been further segmented to cover the in-depth country level analysis. The North American region has been segmented into the U.S. and Canada. Similarly, Europe has been further segmented into the U.K., Germany, France, Italy, Spain, and Rest-of-Europe; Asia-Pacific has been segmented into China, Japan, Australia, India, South Korea, Singapore, and Rest-of-Asia-Pacific; and Latin America and Middle East has been segmented into Mexico, Brazil, and Saudi Arabia. The revenue estimates for these countries is included in the report. 1.2 BIS Research Market Research Methodology The research methodology adopted for this specific study includes a mix of data collected from primary and secondary sources. Both primary sources (in-house experts, industry leaders, and market players) and secondary sources (a host of paid and unpaid databases) along with analytical tools have been used exhaustively to build the forecast and predictive models. Figure 1 BIS Research Market Research Methodology RESEARCH APPROACH SECONDARY RESEARCH PRIMARY RESEARCH DATA SOURCES Company Information  OneSource Business Browser  Hoover’s  10K Wizard  Bloomberg  The Wall Street Journal  Factiva 1. DATABASE FOR KEY INDUSTRY PARTICIPANTS (DKIP) PREPARATION STUDYING THE MARKET STRUCTURE The primary sources from the supply side include industry experts, such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various vendors providing technologysolutions, associatedserviceproviders, andsystem integrators operatingin the targeted regions. E.g. CEOs and VPs/Directors (NewProduct Developmentand Operations) Mainly used to obtain key information about the industry’s value chain and the total pool of key players Subject Information  Scientific Journals  Press Releases  White Paper  Government Stats Centers  Non-Profit Associations  Public and Private Databases IDENTIFY MARKET, TECHNOLOGY, AND COMPETITOR TRENDS 2. DISCUSSION GUIDE PREPARATION Understand market classification and segmentation according to industry trends to the bottom-most level, regional markets, and key developments from both market-and technology-oriented perspectives A detailedquestionnaireis shared with the primaryrespondent coveringallthe aspectsrelated tothereporttopic. Regulation Information • CDC • WHO • FDA • EMA 3. SCHEDULING AN APPOINTMENT Appointments are scheduled with CEO and VP/Director – healthcare companies. The discussion guide is then shared with theprimaryrespondent priortothecall. INTEGRATE INFORMATION Integrate information within relevant documents to form the launchpad for primary research 4. CALL EXECUTION A roundtable discussion is held with the Key Industry Players (KIP) with the aim to gather first-hand information about the technology, recentdevelopmentsin thetechnology,and futureoutlook-growth ordecline. VENDORS CONSULTANT RESELLERS 5. DOCUMENTATION POTENTIAL RESPONDENTS The interviewis recorded and the information gathered through the primaryresearch is put on the drawingboard with the information collected through thesecondaryresearch. Managed Service Providers (MSPs) END USER BIS Research Analysis 8 www.bisresearch.com  sales@bisresearch.com

9. Primary Data Sources The key data points taken from Primary Sources includes: • Validation and Triangulation of all the numbers and graphs • Validation of report segmentation and key qualitative findings • Understanding the competitive landscape • Understanding and considering the market dynamics factors for various market segment and sub- segment • Validation of impact analysis of macro and micro factors in different countries • Percentage split of individual markets for geographical analysis Secondary Data Sources The research study involves the usage of extensive secondary sources such as databases, company websites, and annual reports, among others. The following figure exhibits key secondary data sources considered in this report: Figure 2 Secondary Data Sources STOCK ANALYST WEBSITES COMPANY SOURCES Seeking Alpha Yahoo Finance Wiki Finance The Wall Street Journal Annual Reports Press Releases SEC Filings Investor Presentations Financial Disclosures SECONDARY DATA SOURCES GOVERNMENT AND REGULATORY SOURCES PUBLIC AND PRIVATE DATABASES Medline PubMed National Library of Medicine ProQuest CMS Datasets Medicare Beneficiaries Database The Centre for Disease Control (CDC) The World Health Organization (WHO) The National Health Services (NHS) The National Center for Biotechnology Information (NCBI) The Food & Drug Administration of United States (U.S. FDA) BIS Research Analysis 9 www.bisresearch.com  sales@bisresearch.com

10. The key data points taken from secondary sources include: • Segmentation breakups, split-ups, and percentage shares • Data for market value • Key industry trends of the top players of the market • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation • Quantitative data for mathematical and statistical calculations The following figure exhibits data triangulation considered in this study: Figure 3 Data Triangulation PRIMARY SOURCES SECONDARY SOURCES INTERVIEWS WITH: • Top management of leading companies developing liquid biopsy tests, kits and consumables, and instruments • C-level executives of start-up companies contributing to liquid biopsy market • Scientists and researchers from renowned universities working in the development of novel non-invasive diagnostic tests • Annual reports from the leading players in the liquid biopsy market • National Institute of Health (NIH) INFORMATION SOURCED • Centers for Disease Control (CDC) • US Oncology Research SUPPLY SIDE • The World Bank DATA • Export and Import Regulatory Bodies TRIANGULATION PRIMARY SOURCE SECONDARY SOURCE Annual Reports, SEC Filings, Investor Presentations, Websites, and Press Releases of top players, News Articles, Journals, and Paid Databases INFORMATION SOURCED Opportunities/ Challenges Market Size and Market Share Key Players Competitive Landscape Geographical Analysis Influencing Factors Market Estimates Market Trends BIS Research Analysis REQUEST FOR SAMPLE 10 www.bisresearch.com  sales@bisresearch.com